Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Short-Term Debt issuances (2018 - 2020)

Organogenesis Holdings (ORGO) has 3 years of Short-Term Debt issuances data on record, last reported at -$29.4 million in Q4 2020.

  • For Q4 2020, Short-Term Debt issuances changed N/A year-over-year to -$29.4 million; the TTM value through Dec 2021 reached -$22.4 million, down 45.59%, while the annual FY2021 figure was -$10.0 million, 57.42% up from the prior year.
  • Short-Term Debt issuances reached -$29.4 million in Q4 2020 per ORGO's latest filing, down from $7.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $7.0 million in Q2 2019 and bottomed at -$29.4 million in Q4 2020.
  • Average Short-Term Debt issuances over 3 years is -$248375.0, with a median of $3.8 million recorded in 2018.
  • The widest YoY moves for Short-Term Debt issuances: up 416.6% in 2019, down 46.34% in 2019.
  • A 3-year view of Short-Term Debt issuances shows it stood at $6.2 million in 2018, then increased by 12.0% to $7.0 million in 2019, then crashed by 519.33% to -$29.4 million in 2020.
  • Per Business Quant database, its latest 3 readings for Short-Term Debt issuances were -$29.4 million in Q4 2020, $7.0 million in Q3 2019, and $7.0 million in Q2 2019.